Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 32 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Abicipar pegol for wet age related macular degeneration	Abicipar pegol (AGN-150998)	Age-related macular degeneration (AMD)	Ophthalmology	2018	View \| Download
Acarizax for treating allergic rhinitis or allergic rhinoconjunctivitis in children aged 5 to 11 years old	Acarizax	Allergic rhinitis , Allergic rhinoconjunctivitis	Immunology , Ophthalmology	2024	View \| Download
Aflibercept for previously untreated retinopathy of prematurity in children	Aflibercept	Retinopathy of prematurity	Gynaecology and Obstetrics , Ophthalmology	2023	View \| Download
Avacincaptad pegol for the treatment of geographic atrophy secondary to age-related macular degeneration	Avacincaptad pegol	Age-related macular degeneration (AMD) , Geographic atrophy	Ophthalmology	2023	View \| Download
Bevacizumab gamma for treating neovascular age-related macular degeneration	Bevacizumab gamma	Age-related macular degeneration (AMD)	Ophthalmology	2024	View \| Download
Bimatoprost slow-release for ocular hypertension or open-angle glaucoma	Bimatoprost SR Occular	Ocular hypertension	Ophthalmology	2021	View \| Download
Botaretigene sparoparvovec for treating X-linked retinitis pigmentosa	Botaretigene sparoparvovec	Retinitis pigmentosa	Ophthalmology	2023	View \| Download
Brolucizumab (ESBA1008; RTH258) for neovascular age-related macular degeneration (nAMD)	Brolucizumab (RTH258; ESBA1008; Beovu)	Age-related macular degeneration (AMD)	Ophthalmology	2017	View \| Download
Brolucizumab for visual impairment due to diabetic macular oedema	Brolucizumab (RTH258; ESBA1008; Beovu)	Visual impairment	Endocrine Nutritional and Metabolic Disorders , Ophthalmology	2020	View \| Download
Ciclosporin ophthalmic solution for treating moderate-to-severe keratoconjunctivitis sicca (dry eye disease)	Ciclosporin ophthalmic solution	Keratoconjunctivitis sicca (dry eye disease)	Ophthalmology	2023	View \| Download